TISATO, FRANCESCO
 Distribuzione geografica
Continente #
AS - Asia 4.136
NA - Nord America 1.632
SA - Sud America 767
EU - Europa 619
AF - Africa 78
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.238
Nazione #
SG - Singapore 1.795
US - Stati Uniti d'America 1.519
CN - Cina 914
BR - Brasile 635
HK - Hong Kong 455
VN - Vietnam 409
FR - Francia 269
KR - Corea 201
IT - Italia 81
BD - Bangladesh 68
IN - India 67
GB - Regno Unito 61
JP - Giappone 58
AR - Argentina 52
CA - Canada 51
DE - Germania 41
FI - Finlandia 31
IL - Israele 25
NL - Olanda 25
MX - Messico 24
ID - Indonesia 22
EC - Ecuador 20
ZA - Sudafrica 18
IQ - Iraq 16
PY - Paraguay 15
TN - Tunisia 14
BE - Belgio 13
ES - Italia 12
IR - Iran 12
PK - Pakistan 12
CO - Colombia 11
EG - Egitto 11
RU - Federazione Russa 11
UA - Ucraina 11
AZ - Azerbaigian 10
UZ - Uzbekistan 10
VE - Venezuela 10
CL - Cile 9
MA - Marocco 8
PE - Perù 8
SA - Arabia Saudita 8
TR - Turchia 8
GR - Grecia 7
PL - Polonia 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
KE - Kenya 6
PA - Panama 6
PH - Filippine 6
AL - Albania 5
CR - Costa Rica 4
DK - Danimarca 4
JM - Giamaica 4
JO - Giordania 4
KZ - Kazakistan 4
LT - Lituania 4
MY - Malesia 4
SE - Svezia 4
SI - Slovenia 4
SN - Senegal 4
CH - Svizzera 3
CI - Costa d'Avorio 3
DZ - Algeria 3
GP - Guadalupe 3
KW - Kuwait 3
LV - Lettonia 3
MK - Macedonia 3
NI - Nicaragua 3
NP - Nepal 3
PR - Porto Rico 3
TT - Trinidad e Tobago 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
BZ - Belize 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LY - Libia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RO - Romania 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
BB - Barbados 1
BG - Bulgaria 1
CD - Congo 1
CY - Cipro 1
GA - Gabon 1
GN - Guinea 1
HR - Croazia 1
HU - Ungheria 1
IE - Irlanda 1
LB - Libano 1
Totale 7.223
Città #
Singapore 1.076
Santa Clara 517
Hefei 455
Hong Kong 453
San Jose 267
Lauterbourg 209
Seoul 198
Ho Chi Minh City 143
Beijing 121
Ashburn 106
Hanoi 91
Los Angeles 71
Dallas 67
Guangzhou 46
São Paulo 42
Tokyo 31
New York 28
Rio de Janeiro 28
Helsinki 27
Minamishinagawa 24
Buffalo 19
Frankfurt am Main 19
Haiphong 19
Orem 18
Bengaluru 17
Belo Horizonte 16
Da Nang 15
Toronto 14
Brussels 13
Biên Hòa 12
London 12
Curitiba 10
Tehran 10
Baku 9
Brasília 9
Campinas 9
Can Tho 9
Tashkent 9
Atlanta 8
Dhaka 8
Montreal 8
New Delhi 8
Phoenix 8
Porto Alegre 8
Asunción 7
Brooklyn 7
Johannesburg 7
Manaus 7
Ottawa 7
Quito 7
Quận Một 7
São José dos Campos 7
Uberlândia 7
Athens 6
Chicago 6
Contagem 6
Lấp Vò 6
Milan 6
Nam Định 6
Ninh Bình 6
Padua 6
Philadelphia 6
Phủ Lý 6
Ribeirão Preto 6
Rome 6
Boardman 5
Bình Dương 5
Cape Town 5
Chennai 5
Erbil 5
Formosa 5
Fortaleza 5
Guayaquil 5
Hải Dương 5
Lima 5
Nairobi 5
Naples 5
Poços de Caldas 5
Quảng Ninh 5
Salvador 5
Shanghai 5
São Carlos 5
Thái Nguyên 5
Warsaw 5
Amman 4
Amsterdam 4
Aracaju 4
Baghdad 4
Bauru 4
Berlin 4
Buenos Aires 4
Cairo 4
Camaçari 4
Ciudad del Este 4
Dakar 4
Florence 4
Goiânia 4
Gravataí 4
Ha Long 4
Montevideo 4
Totale 4.581
Nome #
Copper(I) and copper(II) adducts detected under ESI-MS conditions during the study of cytotoxic phosphino Cu(I) complexes. 84
Phthalates and heavy metals as endocrine disruptors in food: A study on pre-packed coffee products 74
Synthesis and characterization of novel 99-technetium(III) phosphine complexes. HPLC characterization and rat biodistribution of the Tc-99m analogs 72
Technetium(V) and rhenium(V) complexes with Schiff-base ligands containing the ONNNO donor atom set. Crystal structure of [N,N?-3-azapentane-1,5-diylbis(salicylideneiminato)(3-)-O,O',N, N',N'']-oxotechnetium(V) 71
From phosphines to water soluble carbenes: synthesis and biological investigation of 11th group metal complexes 71
SYNTHESES AND STRUCTURAL CHARACTERIZATIONS OF 6-COORDINATE OXO-M(V) COMPLEXES (M=TC, RE) CONTAINING A TETRADENTATE P2N2-PHOSPHINO-AMIDO LIGAND 69
New copper(I) phosphane complexes of dihydridobis(3-nitro-1,2,4-triazolyl)borate ligand showing cytotoxic activity 65
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET: physicochemical identification of by-products and degradation species 64
New approach to the chemistry of technetium(V) and rhenium(V) phenylimido complexes: novel [M(NPh)PNP]3+ metal fragments (M = Tc, Re; PNP = aminodiphosphine) suitable for the synthesis of stable mixed-ligand compounds 63
Relationship Between ESI(+)-MS Behavior and Cytotoxic Activity of [MI(P)4]+-type Complexes (M = Cu, Ag, Au; P = Tertiary Phosphane)" 62
Novel TcP3X3 (XS, O) cores in Tc(III) chemistry 61
Synthesis and characterization of the bis(trithioperoxybenzoate) (dithiobenzoate) rhenium( III) hetero complex 58
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)]2+ metal fragments (M = Tc, Re; PXP = diphosphine ligand) 58
Synthesis, characterization and crystal structure of oxobis(p-thiocresolato)terpyridinerhenium(V), a new cationic, six-coordinate thiolato complex of rhenium 57
Gold nanorods - copper(I) complexes conjugates as anticancer drug-delivery system 56
Reactivity of Al(III) with membrane phospholipids: A NMR approach 54
Uncommon Anionic Dioxorhenium(V) and Neutral Monooxorhenium(V) Mixed-Ligand Complexes Containing Heterofunctionalized Phosphine Ligands: Syntheses and Structural Characterization 54
Structure of [Cu(DAPTA)4]+ complex in extremely diluted aqueous solution 52
Experimental Evidences of The Presence of Bimolecular Caffeine/Catechin Complexes in Green Tea Extracts 51
Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase 50
Neutral and charged phosphine/scorpionate copper(I) complexes: Effects of ligand assembly on their antiproliferative activity 50
Copper(I) heteroleptic 3+1 complexes: ligand effect on their in vitro cytotoxicity 49
ESI-MSn study of the interaction products of cytotoxic phosphino copper(I) complexes with model peptides 49
Syntheses and characterization of new rhenium(V)-oxo complexes containing N,N,O-heteroscorpionate ligands 48
Neutral and charged copper(I) complexes on hydrophilic gold nanoparticles and nanorods: loading and structural studies for biomedical applications 48
From tetrahedrical homoleptic phosphino copper (I) complexes [CuP4]+ to low coordinated species: effect on the antiproliferative activity 47
Metabolomic fingerprinting of plant extracts 46
Synthesis, reactivity and cytotoxic properties of water soluble coinage metal N-Heterocyclic Carbene complexes 46
Radioactive Transition Metal Nitride Hetero-Complex 45
Evidence of non-covalent complexes in some natural extracts: Ceylon tea and Mate extracts 45
Coordinative unsaturated CuI entities are crucial intermediates governing cell internalization of copper. A combined experimental ESI-MS and DFT study. 45
Electrospray mass spectrometry, mixed nitrido-Tc heterocomplexes and nuclear medicine 43
Phosphanyl-amino complexes of nickel(II): Synthesis and structure 43
Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines 43
Interaction products of cytotoxic Cu(I) complexes with different solvent mixtures: an electrospray ionization mass spectrometry and density functional theory study 43
Highly Hydrophilic Gold Nanoparticles as Carrier for Anticancer Copper(I) Complexes: Loading and Release Studies for Biomedical Applications 43
Synthesis and characterization of novel tetrahedral copper(I) complexes comprising tridentate PNP-aminodiphosphines and tetradentate PN(X)P-substituted aminodiphosphines (X = O, S) 43
Co-ordination of (o-aminophenyl)diphenylphosphine in complexes containing the [Mv = O]3+ (M = Tc or Re) core 42
Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): Cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands 42
In vitro evaluation of antileishmanial activity of copper (I) complexes 42
[MI(HB(pz)3)(P)] complexes (P = monodentate phosphine): comparison of the antiproliferative activity of silver and copper "3+1" mixed-ligand compounds 42
Electrospray ionization in the study of the interactions between cytotoxic phosphino Cu(i) complexes and selected amino acids and GlyGlyHis peptide model 42
Copper(I) complexes with phosphines P(p-OCH3-Ph)2CH2OH and P(p-OCH3-Ph)2CH2SarGly. Synthesis, multimodal DNA interactions, and prooxidative and in vitroantiproliferative activity 42
Polydentate phosphinoamine ligands: a class of efficient chelating agents for the stabilization of various technetium(V) and rhenium(V) cores 41
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET : physico-chemical identification of by-products and degradation species 41
Synthesis, Characterization and Crystal Structure of the Water Soluble Copper(I) Complex with Trisulfonated Triphenylphosphine 40
Synthesis and Characterization of Mixed-Ligand Zn(II) and Cu(II) Complexes Including Polyamines and Dicyano-dithiolate(2-): In vitro Cytotoxic Activity of Cu(II) Compounds 40
Electrospray ionization study of tricarbonyl fac-[Re(CO)3(PO)(X)]- type complexes: influence of ancillary co-ligands in the release of carbon monoxide 40
Copper Complexes as Anticancer Agents 40
Phosphino copper(I) complexes as potential anticancer agents: physico-chemical and biological properties 39
Contamination of dry foods with trimethyldiphenylmethanes by migration from recycled paper and board packaging 39
Syntheses and characterisation of rhenium-(III) and -(V) complexes containing aminophosphine ligands. Crystal structures of [Re-V(OCl2)(OMe)L] and [Re-III(Cl3L)(PPh3)], L equals o-(diphenylphosphino)-N,N'-dimethylaniline 39
Phosphine-copper(I) complexes as anticancer agents: design, synthesis, and physicochemical characterization. Part I 39
Synthesis and characterization of Oxorhenium(V) Complexes Containing o-diphenylphosphinophenolato and monothiolato lingands 38
Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules 38
Contribution of electrospray mass spectrometry for the characterization, design, and development of nitrido technetium and rhenium heterocomplexes as potential radiopharmaceuticals 38
Electrospray ionization multi-stage mass spectrometric study of the interaction products of the cytotoxic complex [Cu(thp)4][PF6] with methionine-rich model peptides 38
Copper in Diseases and Treatments, and Copper-Based Anticancer Strategies 37
Synthesis and characterization of mixed-ligand Zn(II) and Cu(II) complexes including polyamines and dicyanodithiolate: in vitro cytotoxic activity of Cu(II) compounds 37
Characterization of the designer drug deschloroketamine (2-methylamino-2-phenylcyclohexanone) by gas chromatography/mass spectrometry, liquid chromatography/high-resolution mass spectrometry, multistage mass spectrometry, and nuclear magnetic resonance 37
Cu(I) Complexes Bearing Phosphines Derived From Hydrophilic SarGly -Physicochemical and Biological Characteristics 37
In vitro antitumor activity of water-soluble copper(I) complexes with diimine and monodentate phosphine ligands 37
Synthesis of new copper(I) complexes with hydrophilic aminomethylphosphines 36
Evaluation of anti-Leishmania activity induced by silver metal complexes against leishmania amazonensis and leishmanial guyanensis 36
Low-Valent Technetium Complexes with Aminodiphosphines 36
Phosphine copper(I) complexes as anticancer agents: biological characterization. Part II 36
ESI-MSn study of the interaction products of a cytotoxic phosphino copper(I) complex with methionine-rich peptides 36
On the presence of non-covalent complexes in natural extracts 36
A NEW PHASE OF BIS[2-(DIPHENYLPHOSPHINO-K-P-PHENYLAZANIDO-K-N](ETHANOLATO)(OXO)-RHENIUM(V) 35
[Cu(thp)4]n[X]-n compounds for the treatment of a broad range of human solid tumors, including refractory tumors. 34
Mixed-Ligand Rhenium-188 Complexes with Tetradentate/Monodentate NS3/P ('4 + 1') Coordination: Relation of Structure with Antioxidation Stability 34
Rhenium(I) Tricarbonyl Complexes with (2-Hydroxyphenyl)diphenylphosphine as PO Bidentate Ligand 34
The [99mTc(N)(PNP)]2+ Metal Fragment : A Technetium-Nitrido Synthon for use with Biologically Active Molecules. The N-(2-Methoxyphenyl)piperazyl-cysteine Analogues as Examples. 34
Synthesis of a novel class of trigonal bipyramidal nitrido Tc(V) complexes with phosphino-thiol ligands. Crystal structure of [Tc-99g(N)(L-1)(2)] [L-1=2-(diphenylphosphino)ethanethiolato] and [Tc-99g(N)(L-5)(2)] [L5=2-(ditolylphosphino)propanethiolato] 33
Tc and Re Nitrido Asymmetrical Heterocomplexes. A '2+2' Approach 33
ESI(+)MS and DFT studies on the internalization of copper in tumour cells: copper(II)/copper(I) interplay at the hCtr1 substrate 33
Cu(I) and Ag(I) complex formation with the hydrophilic phosphine 1, 3, 5 triaza-7-phosphadamantane in different ionic media. How to estimate the effect of a complexing medium 33
ESI in the study of the interactions between phosphino-Cu(I) complexes and Cu(II) salts with model peptides relevant to human copper transporters (hCTR) 32
Reactivity of Bi- and Tetra-Dentate Phosphinoamine Ligands Toward Technetium and Rhenium 32
Syntheses and characterization of amino and amido-imido technetium(V) and rhenium(V) complexes with (o-aminophenyl)diphenylphosphine-N,P. Crystal structures of [TcNCl{PPh2(C6H4NH2-2)} 2]Cl·MeCN and [Re{PPh2(C6H4N-2)}Cl2{PPh 2(C6H4NH-2}] 32
Synthesis and characterization of nitrido Tc(V) and Re(V) complexes with ferrocenedithiocarboxylate {FcCS(2)=[Fe(C5H4CS2)(C5H5)](-)} 32
Trigonal-Bypyramidal Tc(V) and Tc(III) Complexes with Mixed S,P-Bidentate Phosphine-Thiols 31
Hydrophilic gold nanoparticles and nanorods as drug delivery systems for anticancer copper complexes 31
Complessi azoturo dissimmetrici monocationici di metalli di transizione radioattivi 31
Syntheses and reactivity of sulphur rich Re(III) and Tc(III) complexes containing trithioperoxybenzoate, dithiobenzoate and dithiocarbamate ligands 31
Hydrophilic gold nanoparticles and nanorods as drug delivery systems for anti cancer copper complexes 31
Synthetic routes to mono-N-functionalized P2N2-ligands 31
(2-Hydroxyphenyl)diphenylphosphine as fac-[Re/Tc-99m(CO)(3)](+)-ligand 31
Neutral fac-[Re(I)/Tc-99m(I)(CO)(3)](+)-complexes with the new PO/L-donor system 31
Alternative Synthesis of Aminodiphosphines 31
Technetium coordination chemistry; development of new backbones for 99mTc radiopharmaceuticals 30
A mass spectrometric investigation of a series of [ReOX(PY)(2)] complexes containing bidentate phosphinophenolate and phosphinoamine ligands 30
The metal-fragment strategy for the construction of stable Tc and Re mixed-ligand compounds relevant to nuclear medicine 30
ESI/MSn in the structural characterisation of some nitrido-Re heterocomplexes 30
'Complessi carbenici N-eterociclici simmetrici e asimmetrici dei metalli da conio: sintesi, citotossicità e studi in soluzione 30
Synthesis and characterization of [dichloro[hydrotris(1-pyrazolyl)borate]sulfido-technetium(V)] and [bis-(u-ethane-1,2-dithiolato)-bis-(ethene-1,2-dithiolato)-technetium(IV)] complexes. The first evidence of a terminal Tc=S multiple bond 29
SYNTHESIS AND CHARACTERIZATION OF TECHNETIUM(V) AND RHENIUM(V) OXO-COMPLEXES WITH SCHIFF-BASE LIGANDS CONTAINING THE ONN DONOR-ATOM SET - MOLECULAR-STRUCTURE OF TRANS-DICHLORO-OXO[1-(8'-QUINOLYLIMINOMETHYL)-2-NAPHTHOLATO-NN'O]TECHNETIUM(V) 29
The relationship between the electrospray ionization behaviour and biological activity of some phosphino Cu(I) complexes 29
Synthesis, solution-state and solid-state structural characterization of monocationic nitrido heterocomplexes [M(N)(DTC(PNP)](+) (M=Tc-99, Re; DTC = dithiocarbamate; PNP=heterodiphosphane) 29
Synthesis of a series of Cu(I) derivatives containing PTA, PTAH and mPTA ligands and evaluation of their cytotoxic activity 29
Totale 4.230
Categoria #
all - tutte 29.424
article - articoli 18.292
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 552
Totale 48.268


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202451 0 0 0 0 0 0 0 0 2 0 48 1
2024/20252.667 8 19 220 134 428 141 36 71 35 53 806 716
2025/20264.520 270 457 500 755 791 162 674 203 217 200 128 163
Totale 7.238